REGISTER HERE TO JOIN US
PROGRAM BROCHURE
Program Agenda

Overview

CVI’s 2026 Cardiology Fellows Program has been expanded to provide a comprehensive and contemporary educational experience spanning the full spectrum of cardiovascular medicine. In addition to core interventional cardiology content, the program now includes major clinical cardiology topics such as Electrophysiology, Cardiovascular Imaging, Heart Failure, Hypertrophic Cardiomyopathy, Amyloidosis, HFpEF, Health Equity, Lipid Disorders, and Coronary Artery Disease. The program also features advanced interventional and structural heart disease sessions focused on Myocardial Infarction, Left Main Revascularization, Complications of PCI, TAVR Fundamentals, Asymptomatic Aortic Stenosis, Tricuspid Regurgitation, and Cardiac Hemodynamics and Shock.
By integrating prevention, advanced imaging, heart failure, electrophysiology, structural heart disease, and complex coronary intervention into one educational forum, the 2026 Fellows Program offers a uniquely comprehensive and well-rounded learning experience designed specifically for today’s cardiology fellows. This expanded curriculum makes the program a premier “must-attend” educational opportunity for fellows seeking practical, evidence-based, and state-of-the-art cardiovascular education.

Learning Objectives

Learning Objectives View/Download

Clinical Case Poster Submission

CVI is pleased to invite submissions of clinical cases for presentation at the 2026 Cardiology Fellows Program. Accepted cases will be published in a supplementary edition of Heart International.

  • Submission Deadline: Friday, September 4, 2026, at 5:00 PM ET
  • Authors interested in presenting a clinical case should review the submission requirements and formatting instructions by clicking the Guidelines button below.
  • To submit your case, click the Submission button below and upload all required materials by the deadline.
  • Top-scoring submissions will be selected for oral presentation, with additional selected cases featured as E-posters during the program, providing valuable opportunities for scholarly discussion and peer engagement.

Complimentary Loews Hotel Accommodations


Diverse and dynamic Philadelphia has plenty to offer visitors, from centuries of history and top-ranked museums to trendy neighborhoods,
exceptional restaurants and an exciting nightlife.

Complimentary Loews Hotel overnight room accommodations are available for Friday, Oct. 9 and Saturday night October 10 (for those travelling from out of town) with early registration before September 28, 2026.

Course Director

Sheldon Goldberg, MD
Sheldon Goldberg, MDUniversity of Pennsylvania

Associate Directors

Sahil Banka, MD
Sahil Banka, MDEinstein Medical Center
Veronica Covalesky, MD
Veronica Covalesky, MDThomas Jefferson University
Victor Ferrari, MD
Victor Ferrari, MDUniversity of Pennsylvania
Paul Fiorilli, MD
Paul Fiorilli, MDUniversity of Pennsylvania
William Gray, MD
William Gray, MDMain Line Health System
Ellen Keeley, MD
Ellen Keeley, MDUniversity of Florida-Gainesville
Bryan Kluck, DO
Bryan Kluck, DOLehigh Valley Health Network
Richard Kovach, MD
Richard Kovach, MDDeborah Heart and Lung Center
Joanne Mazzarelli, MD
Joanne Mazzarelli, MDCooper University Health Care
D. Lynn Morris, MD
D. Lynn Morris, MDEast Carolina University
Antonis Pratsos, MD
Antonis Pratsos, MDMain Line Health
Troy Randle, DO
Troy Randle, DORowan-Virtua School of Osteopathic Medicine
Muhammad Raza, MD
Muhammad Raza, MDDeborah Heart and Lung Center
Michael Savage, MD
Michael Savage, MDThomas Jefferson University
Frank Silvestry, MD
Frank Silvestry, MDUniversity of Pennsylvania

Faculty

FACULTY

Fellow Case Presenters

Agenda/Brochure

Download Agenda
Download Brochure

Register for CVI Fellows 2026

REGISTER HERE TO JOIN US

Parking

Parking at the hotel is valet and the entrance is on 12th Street just below Market Street.  If you are planning an overnight stay, please valet park at the Loews Hotel.
For convenient self-parking near the Loews Hotel (12th and Market), your best options are the following facilities located within a 1 to 3-minute walk and offer safe, 24/7 indoor self-parking:
1. East Market Garage (Park America)
•Location: 15 S. 12th St., Philadelphia, PA 19107
•Distance to Loews: ~250 feet (< 1 minute walk)
•Features: Indoor, 24/7 access, self-parking.

2. Wanamaker Building Garage (LAZ Parking)
•Location: 84 S. 13th St. (or 1301 Chestnut St.), Philadelphia, PA 19107
•Distance to Loews: 1 block away (3-minute walk)
•Features: Indoor garage with roughly 660 spots. A very popular and secure option.

3. Parkway Corp – 12th & Filbert Garage
•Location: 1201 Filbert St., Philadelphia, PA 19107
•Distance to Loews: 1.5 blocks north (3-minute walk)
•Features: Brightly lit and highly rated for its cleanliness.

.

Thanks to our Elite Sponsors

Session 8 – 12/7/2021

Tuesday December 7, 2021 at 6:45pm
“The Clinical Conundrum of Cardiogenic Shock”
Guest Faculty & Moderator

Sanjog Kalra, MD
University of Toronto
Moderator

D. Lynn Morris, MD
East Carolina University

View Session 8 Agenda
Fellows Program Brochure

Session Description

Despite enormous advances in the therapy of acute myocardial infarction, with marked reduction in death, the mortality for patients with cardiogenic shock remains unacceptable high.  In this interactive program, the definition, classification and new approaches to therapy of cardiogenic shock will be discussed.

Learning Objectives

After viewing this session, attendees will be better able to:

  • Describe the definition and pathophysiology of cardiogenic shock due to ischemic and non ischemic causes
  • Utilize appropriate revascularization strategies for shock due to myocardial infarction
  • Select appropriate mechanical circulatory support devices, including intra-aortic balloon counterpulsation, axial flow pumps ( Impella), left atrial-femoral bypass (Tandem Heart) and ECMO.
Register Online for Session 8 – 12/7/21
Register Online for Session 1 – 4/20/21
Register Online for Session 2 – 5/18/21
Register Online for Session 3 – 6/15/21
Register Online for Session 4 – 7/20/21
View Program Information
Register By Mail

View Recorded Session 7 – 11/16/2021

Tuesday November 16, 2021 at 6:45pm
“Diagnosis and Management of Pulmonary Embolism”
Guest Faculty & Moderator

Jay Giri, MD
University of Pennsylvania
Moderator

Bryan Kluck, DO
Fellow Case Presenters
       
Storm de Klerk, MD          Hillary Cox-Johnston, MD

Session Description

This interactive CVI Fellows session includes case presentations by fellows and a state-of-the-art review on the diagnosis, classification, and management of patients with acute pulmonary embolism.

Learning Objectives

After viewing this session, attendees will be better able to:

  • Describe the clinical presentation, classification, and pathophysiology of acute pulmonary embolism
  • Explain the utility of various diagnostic modalities
  • Select the most appropriate therapeutic approach, including catheter based and surgical therapies
Register Online for Session 7 – 11/16/21
View Session 7 Agenda
Fellows Program Brochure

View Recorded Session 6 – 10/19/21

Tuesday October 19, 2021 at 6:45pm
“Treatment of Patients with Aortic Stenosis-from Hemodynamic Principles to Valve Replacement in the TAVR Era”
Guest Faculty

James Hermiller, MD
The Heart Center of Indiana
Moderators
   
Muhammad Raza,MD   Paul Fiorilli, MD
Fellow Case Presenters
   
Rim Halaby, MD            Kevin Ball, MD

Session Description

This interactive CVI Fellows session focuses on hemodynamic principles and imaging techniques to evaluate AS severity, including the full range of aortic stenosis from normal flow, high gradient AS through low flow, low gradient AS.  The evaluation and workup of the AS patient will be reviewed, including imaging and planning for TAVR.  TAVR procedural techniques and best practices will be discussed, including the challenging situations of coexistent CAD, bicuspid valves, embolic protection and challenging vascular access.

Learning Objectives

After viewing this session, attendees will be better able to:

  • Utilize clinical, hemodynamic and imaging findings to assess the severity of aortic stenosis
  • Describe the pathophysiology and clinical outcomes of patients with low flow, low gradient AS
  • Recognize challenges posed by patients with coexistent CAD, bicuspid valves, challenging vascular access, and to discuss techniques and data for embolic protection for stroke prevention during TAVR
On Demand Access for Session 6 – 10/19/21
View Session 6 Agenda
Fellows Program Brochure

Session 5 – 9/28/21

Tuesday September 28, 2021 at 6:45pm
“Complex Coronary Intervention:
Prepare for the Worst and Hope for the Best”
Guest Faculty

Emmanouil Brilakis, MD
Minneapolis Heart Institute
Moderators
   
Richard Kovach, MD     Antonis Pratsos, MD
Fellow Case Presenters
      
Yashasvi Chugh, MD    Rita Butler, MD              Adam Burow, DO

Fellows Program Brochure

Session Description

<p><strong>Session Description</strong></p><p>The use of adjunctive antiplatelet and antithrombotic strategies for PCI will be the focus of this case-based session.  The role of heparin vs bivalirudin, 2b/3a inhibitors, intravenous antiplatelet agents, and the various P2Y12 inhibitors will be discussed.  We will compare clopidogrel, prasugrel, ticagrelor, and cangrelor in real-world practice.  The critical issue of duration of dual antiplatelet therapy will be reviewed with emphasis on clinical presentation, lesion complexity, bleeding risk and the stent/drug interface.  Finally the specific issue of PCI in patients requiring anticoagulation for atrial fibrillation will be addressed.</p><p><strong>Learning Objectives</strong></p><p>After viewing this session, attendees will be better able to:</p><ul><li>Recognize the benefits and risks of the various anticoagulant and antiplatelet agents used in conjunction with PCI</li><li>Understand the factors which influence drug selection and duration of dual antiplatelet therapy</li><li>Address various strategies when combined anticoagulation and antiplatelet are required, for example, PCI in patients with atrial fibrillation</li></ul>

Complex coronary intervention requires careful planning, not only for the procedure itself, but also for the potential complications inherent in these types of procedures.  The importance of the heart team approach to these patients will be the starting point for discussion.  We will review the approach to patients with calcified lesions, left main and bifurcation disease and LV dysfunction.  Lesion preparation by rotational or orbital atherectomy, and lithotripsy, provisional vs bifurcation stenting and the role of LV support by IABP or Impella will be addressed.

Learning Objectives

After viewing this session, attendees will be better able to:

  • Appreciate and understand the importance of the heart team approach in managing patients with complex and high-risk coronary anatomy
  • Identify and define what constitutes high risk and complex PCI
  • Construct a logical and appropriate interventional plan for complex coronary cases
  • Anticipate potential complications of complex and high-risk PCI while simultaneously having a plan to rapidly deal with them if they occur
Register Online for Session 5 – 9/28/21
View Session 5 Agenda

View Recorded Session 5

SESSION 5 – “Complex Coronary Interventions: Prepare for the Worst, Hope for the Best”

Tuesday September 28, 2021 at 6:45pm
“Complex Coronary Intervention:
Prepare for the Worst and Hope for the Best”
Guest Faculty

Emmanouil Brilakis, MD
Minneapolis Heart Institute
Moderators
   
Richard Kovach, MD     Antonis Pratsos, MD
Fellow Case Presenters
      
Yashasvi Chugh, MD    Rita Butler, MD              Adam Burow, DO

Session Description

The use of adjunctive antiplatelet and antithrombotic strategies for PCI will be the focus of this case-based session.  The role of heparin vs bivalirudin, 2b/3a inhibitors, intravenous antiplatelet agents, and the various P2Y12 inhibitors will be discussed.  We will compare clopidogrel, prasugrel, ticagrelor, and cangrelor in real-world practice.  The critical issue of duration of dual antiplatelet therapy will be reviewed with emphasis on clinical presentation, lesion complexity, bleeding risk and the stent/drug interface.  Finally the specific issue of PCI in patients requiring anticoagulation for atrial fibrillation will be addressed.

Learning Objectives

After viewing this session, attendees will be better able to:

  • Recognize the benefits and risks of the various anticoagulant and antiplatelet agents used in conjunction with PCI
  • Understand the factors which influence drug selection and duration of dual antiplatelet therapy
  • Address various strategies when combined anticoagulation and antiplatelet are required, for example, PCI in patients with atrial fibrillation

View Recorded Session 4

SESSION 4 – “Optimal Interventional Pharmacology: Tailoring the Drug to the Specific Patient”

Held Tuesday July 20, 2021 at 6:45pm
“Optimal Interventional Pharmacology: Tailoring the Drug to the
Specific Patient”
Guest Faculty

Roxana Mehran, MD
Mt. Sinai School of Medicine
Moderators
   
D. Lynn Morris, MD       Michael Savage, MD
Panelists
     
Bryan Kluck, DO              Alec Vishnevsky, MD
Fellow Case Presenters 
    
Anton Camaj, MD           John Lawrence, MD      

Session Description

The use of adjunctive antiplatelet and antithrombotic strategies for PCI will be the focus of this case-based session.  The role of heparin vs bivalirudin, 2b/3a inhibitors, intravenous antiplatelet agents, and the various P2Y12 inhibitors will be discussed.  We will compare clopidogrel, prasugrel, ticagrelor, and cangrelor in real-world practice.  The critical issue of duration of dual antiplatelet therapy will be reviewed with emphasis on clinical presentation, lesion complexity, bleeding risk and the stent/drug interface.  Finally the specific issue of PCI in patients requiring anticoagulation for atrial fibrillation will be addressed.

Learning Objectives

After viewing this session, attendees will be better able to:

  • Recognize the benefits and risks of the various anticoagulant and antiplatelet agents used in conjunction with PCI
  • Understand the factors which influence drug selection and duration of dual antiplatelet therapy
  • Address various strategies when combined anticoagulation and antiplatelet are required, for example, PCI in patients with atrial fibrillation

View Recorded Session 3

SESSION 3 – “How Should I Use FFR/iFR, IVUS, OCT and NIRS In Preparation for PCI And to Assess My Results”

Held Tuesday June 15, 2021 at 6:45pm
“How Should I Use FFR/IFR, IVUS, OCT and NIRS in Preparation for PCI and to Assess My Results”
Guest Faculty

James Goldstein, MD
Beaumont Health
Moderators
       
Sahil Banka, MD                Ellen Keeley, MD
Fellow Case Presenters
                
Mohammad AlSarie MD   Jason Schott, DO               Morgan Randall, MD

SESSION DESCRIPTION

This CVI Fellows 2021 interactive session reviews the scientific basis for and clinical importance of the various imaging technologies in pre-PCI assessment of lesion characteristics and lesion severity.  Additionally, the evaluation of post procedure results to minimize the risks of stent thrombosis and restenosis will be discussed.

Learning Objectives
After viewing this session, attendees will be better able to:

  • Describe the role of coronary imaging technologies in real work clinical practice
  • Select the most appropriate technology to characterize lesions prior to and after PCI

View Recorded Session 2

SESSION 2 – “Fundamentals of Coronary Intervention: How to Fly on My Own”

Session 2 – 5/18/21

Held Tuesday May 18, 2021 
“Fundamentals of Coronary Intervention: How to Fly on My Own”
Guest Faculty

Farouc Jaffer, MD
Harvard Medical School
Moderators
        
Richard Kovach, MD        Muhammad Raza, MD
Fellow Case Presenters
       
Michael Bode, MD             Parthiv Amin, MD

Session Description

This CVI Fellows 2021 interactive session teaches the basics for achieving a safe and successful PCI, beginning with optimal angiographic views, and following through to definitive treatment and procedure completion. Specifics will involve basic decisions on vascular access site and guide catheter choice. Techniques for optimal visualization of the coronary arteries with focus on accurate target lesion assessment will be discussed.  Balloon and stent choices, as well as when adjunctive therapies such as atherectomy might be useful will be covered. Specific attention as to how these choices contribute to successful stent delivery, optimal deployment and long-term patency will also be a point of focus.

Learning Objectives
After viewing this session, attendees will be better able to:

  • Describe techniques for accurate lesion/vessel assessment and optimal coronary revascularization
  • Discuss how to logically choose interventional devices including guide catheters, wires, stents, and atherectomy devices, rotational, orbital and lithotripsy
  • Explain the techniques that will result in successful stent delivery and optimal stent deployment

View Recorded Session 1

SESSION 1 – “The Art and Science of STEMI”

Guest Faculty

J Dawn Abbott, MD
Brown University 

Moderators                         
               
Sheldon Goldberg, MD     Ellen Keeley, MD                David Goldberg, MD

Fellow Case Presenters
                 
Christopher Lee, MD   Karla Astorius Gonzalez MD  Adam Syed Hafeez, MD                                                                                                                           

Session Description
This CVI Fellows ‘21 session provides an in-depth review of the critical issues in STEMI treatment based on the most recent science and guideline recommendations. This interactive session incorporates fellow case presentations, and focused expert lecture and comments with ample opportunities for audience questions. Specific topics to be addressed during this session include:

  • Emergency pharmacologic management
  • Choice of antiplatelet and anticoagulant drugs: beta blockers, ACE/ARB inhibitors, statins
  • Choice of stents and new stent technologies including the status of thrombus removal and revascularization strategies in patients with multi-vessel disease.
  • Aftercare and follow up including time course of myocardial stunning, indications for defibrillators, the problem of LV thrombus.

Learning Objectives: After viewing this session, attendees will be better able to:

  • Perform effective reperfusion of myocardium at risk
  • Select optimal stent strategy
  • Select patients for non-culprit vessel PCI- who is a candidate, and when to perform